Flow Cytometry Market to Expand at a Healthy Growth Rate in the Coming Years

 

The major factors driving the growth of the flow cytometry market are the technological advancements in flow cytometers, increasing adoption of flow cytometry techniques in research activities & clinical trials, the growing focus on immunology and immuno-oncology research, increasing incorporation of AI platforms in flow cytometry workflows & advancements in flow cytometry software, high incidence and prevalence of HIV-AIDS & cancer, and availability of novel application-specific flow cytometry products.

What the Market Looks Like?

The global Flow cytometry market size is projected to reach USD 6.4 billion by 2025 from USD 4.0 billion in 2019, at a CAGR of 8.3%.

On the basis of technology, the global Flow Cytometry Reagents and Consumables Market is segmented into cell-based and bead-based flow cytometry. The bead-based flow cytometry segment is estimated to witness the highest growth during the forecast period. This technology offers various procedural advantages over other cell-based assays, such as the capacity to detect multiple analytes (also known as multiplexing), high reproducibility, stability, and speed.

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584

What Drives the Market?

The growth of the global market for Flow Cytometry is primarily influenced by the following factors:

• Technological Advancements
• Increasing Incorporation of Ai Platforms in Flow Cytometry Workflows and Advancements in Flow Cytometry Software
• Growing Adoption of Flow Cytometry Techniques in Research and Academia
• Growing Public-Private Initiatives in the Field of Immunology and Immuno-Oncology Research
• Rising Global Incidence and Prevalence of Hiv/Aids and Cancer
• Increased Availability of Application-Specific Products

Geographically, the market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to account for the largest share of the global market in 2019. The favorable business environment, continuously growing number of research activities, the rising number of drug discovery initiatives by US-based pharmaceutical & biotechnology companies, and the strong presence of key players are factors propelling the growth of the North American flow cytometry industry.

Know more about Flow Cytometry Market: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=65374584  

High-performance Liquid Chromatography (HPLC) Market worth $5.7 billion by 2025

The growth in this market is driven byhigh sensitivity &accuracy of the HPLC technique, the growing importance of HPLC tests in drug approvals,the rising popularity of hyphenated techniques, and increasing pharmaceutical R&D spending. However, the high cost of HPLC systems is expected to restrict market growth to a certain extent.

The report High-performance Liquid Chromatography (HPLC) Market is projected to reach USD 5.7billion by 2025 from USD 4.5billion in 2020, at a CAGR of 4.6% during the forecast period.

Download PDF Brochure :- 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=117899209

Market Segmentation: -

Based on the product, the market was divided into instruments, consumables, and accessories. The instrument market is subjected to account for the largest share in the HPLC market and consumables to growth at the highest rate during the forecast period. The need to analyze compounds in trace concentration and the extensive use of the system in forensic institutes and industries such as pharmaceuticals, food, nutraceuticals, cosmetics, and environmental testing calls for growth of the segment.

Based onthe application, the HPLC market is divided into clinical research, diagnostics, forensics, and other applications. Clinical research is subjected to grow at the highest rate in the forecast period. A rise in pharmaceutical and biotechnological research fueled by the need for numerous preclinical and clinical studies performed during the drug discovery and development processis said to drive the market.

Regional Analysis:-

North America is expected to account for the largest share of the global HPLC market. Market growth in this region is driven primarily by the increase in R&D funding, the growing number of preclinical activities by CROs &pharmaceutical companies, and the increasing food & agricultural industry in Canada.

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=117899209

Top Key Players :-

The global HPLC market is well established owing to the dominance of prominent market players, such as Waters (US), Agilent (US), Shimadzu (Japan), Thermo Fisher (US), PerkinElmer (US), GE Healthcare (US), Bio-Rad (US), Merck Millipore (Germany), Hitachi (Japan), Showa Denko (Japan), Gilson (US), Phenomenex (US), JASCO (US), Hamilton Company (US), SIELC (US), Orochem (US), YMC Co. Ltd. (Japan), Restek (US), Trajan Scientific (Australia), and Tosoh Bioscience LLC (Japan).

Nerve Repair and Regeneration Market: Trends and Developments

Growth in this market is driven mainly by high incidence of nerve injuries, the growing prevalence of neurological disorders, and rising government support for neurologic disorder research.

The global Nerve Repair and Regeneration Market size is projected to reach USD 9.7 billion by 2025 from USD 6.3 billion in 2020, growing at a CAGR of 9.1% from 2020 to 2025.

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=883

Market Segmentation:-

By product, the nerve repair market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment is segment is expected to grow at the highest growth rate during the forecast period. The large market share of this segment is driven mainly by rising government expenditure for neurologic disorders, and favorable reimbursement.

Based on the neurostimulation and neuromodulation application, the nerve regeneration market is segmented the neurostimulation and neuromodulation devices market is segmented into internal neurostimulation and neuromodulation applications and external neurostimulation and neuromodulation applications. The internal neurostimulation and neuromodulation segment is estimated to register the highest CAGR during the forecast period.

Based on application, the biomaterials market is segmented into direct nerve repair/neurorrhaphy, nerve grafting, and stem cell therapy. In 2019, the direct nerve repair segment accounted for the largest share of the market.

Recent Developments:-

• In 2020, Medtronic received CE approval for InterStim Micro neurostimulator and InterStim SureScan MRI leads — clearing the technologies for commercial sale and clinical use in Europe
• In 2019, Boston Scientific received FDA approval for the Image Ready MRI for its Vercise Gevia Deep Brain Stimulation System
• In 2020, LivaNova entered into partnership with Verily (US) for evaluation of the effectiveness of Vagus Nerve Stimulation Therapy (VNS Therapy) for difficult-to-treat Depression (DTD)

Regional Analysis:-

The nerve repair market is segmented into five major regions, namely, Europe, North America, the Asia Pacific, Latin America, and Middle East & Africa. In 2019, North America accounted for the largest share of the nerve repair and regeneration industry, followed by Europe.

Speak To Analyst: – https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=883

Top Key Players:-

Some of the major players operating in the global nerve repair market include Medtronic, PLC. (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), AxoGen, Inc. (US), Baxter International, Inc. (US), LivaNova, PLC. (UK), Integra LifeSciences (US), Polyganics (Netherlands), NeuroPace, Inc. (US), Soterix Medical, Inc. (US), Nevro Corp (US), Synapse Biomedical, Inc. (US), Aleva Neurotherapeutics (Switzerland), Collagen Matrix, Inc. (US), KeriMedical (Switzerland), BioWave Corporation (US), NeuroSigma (US), tVNS Technologies GmbH(Germany), and GiMer Medical (Taiwan).

Surgical Robots Market: Trends and Developments

The technological advancements in surgical robots, the increasing adoption of surgical robots, the various advantages of robotic-assisted surgery, and the increase in funding for medical robot research are the key drivers of the surgical robots market. Increasing penetration of surgical robots in ASCs and emerging markets are also supporting the growth of this market.

The Surgical Robots Market  is expected to reach USD 11.8 billion by 2025 from USD 6.7 billion in 2020, at a CAGR of 12.1%.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256618532

Market Segmentation:-

The surgical robots market is segmented based on product & service into robotic systems, instruments & accessories, and services. The instruments & accessories segment is expected to command the largest share of the market in 2020 and is estimated to grow at the highest CAGR during the forecast period. The recurrent purchase of instruments & accessories as opposed to robotic systems, which are a one-time investment, is the major factor driving the growth of this product segment.

The market is segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications based on applications. The general surgery applications segment is estimated to command the largest share of the market in 2020, and this segment is also projected to register the highest CAGR owing to increased use of surgical robots in general procedures such as bariatric surgery, Heller myotomy, gastrectomy, hernia repair, cholecystectomy, transoral surgery, and pancreatectomy.

Market Drivers:-
1 Advantages of Robotic-Assisted Surgery
2 Technological Advancements
3 Increasing Adoption of Surgical Robots
4 Increase in Funding for Medical Robot Research

Regional Analysis:-

North America is expected to dominate the global surgical robots market in 2020, the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the increasing demand from key markets such as Japan and China and the large patient population in India. Due to this, the availability of robots has also grown in this region.

Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=256618532

Top key Players:-

The major players operating in the surgical robots market include Intuitive Surgical (US), Stryker (US), and Medtronic (Ireland).

mHealth Solutions Market to Progress at a Healthy CAGR in Coming Years

The growing adoption of smartphones, increasing penetration of 3G/4G networks, rising focus on cost containment in healthcare delivery, and the increasing demand for home healthcare services are some of the key factors driving the growth of this market.

The report mHealth Solutions Market is projected to reach USD 213.6 billion by 2025 from USD 50.8 billion in 2020, at a CAGR of 33.3 % during the forecast period.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1232

Market Segmentation:-

Based on product and service, the Mobile Health Apps Market segment accounted for the largest share of the mHealth solutions market in 2019. The large share of this segment can be attributed to the high and growing penetration of smartphones and healthcare apps and the rising incidence of chronic and lifestyle-related diseases across the globe (coupled with the effective utilization of apps in chronic disease management).

Key Market Drivers :-
1 Increasing Penetration of Smartphones, Tablets, and Other Mobile Platforms
2 Increasing Utilization of Connected Devices and mHealth Apps for the Management of        Chronic Diseases
3 Cost Containment in Healthcare Delivery
4 Robust Penetration of 3G and 4G Networks for Uninterrupted Healthcare Services
5 Rising Focus on Patient-Centric Healthcare Delivery
6 Increasing Demand for Home Healthcare Services

Regional Analysis:-

Based on region, the Medical Apps Market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest market share in 2019.

Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1232

Top Key Players:-

The prominent players in the Mobile Health Apps Market are Medtronic plc (Ireland), Apple, Inc. (US), AirStrip Technologies (US), AliveCor, Inc. (US), Nike, Inc. (US), Koninklijke Philips N.V. (Netherlands), Johnson & Johnson (US), Omron Corporation (Japan), BioTelemetry, Inc. (US), athenahealth, Inc. (US), AgaMatrix, Inc. (US), Withings S.A. (France), and iHealth Labs, Inc. (US).

 

Hollow Fiber Filtration Market to Witness Steady Growth in the Near Future

The growth of this market can be attributed to the rising preference for continuous manufacturing in the biopharmaceutical industry and the increasing demand for biopharmaceuticals across the globe.

The report Hollow Fiber Filtration Market  is projected to reach USD 517.4 million by 2023 from USD 274.7 million in 2018, growing at a CAGR of 13.5%.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267011039

Market Segmentation:-

On the basis of application, the hollow fiber filtration market is segmented into continuous cell perfusion, harvest and clarification, and concentration and diafiltration. In 2018, continuous cell perfusion is expected to be the largest application segment in the hollow fiber filtration market. The biopharmaceutical industry is actively exploring the potential of continuous manufacturing, with a focus on upstream perfusion cell-culture processes that utilize hollow fiber filters. Due to the advantages of hollow fibers, such as achieving efficient cell separation (with low shear) and allowing robust large-scale manufacturing, they are considered as the most suitable form of membrane filters for TFF and ATF perfusion processes.

On the basis of material, the Hollow Fiber Filtration Industry is segmented into polymeric and ceramic materials. In 2018, the polymeric hollow fiber filtration segment is expected to account for a larger share of the market as these filters are widely used in several ultrafiltration and microfiltration applications, including filtration, desalination, and biochemical reactions.

Key Market Drivers: -
            1 Rising Preference for Continuous Manufacturing
            2 Increasing Demand for Biopharmaceuticals

Regional Analysis:-

The Asian Pacific is expected to be the fastest-growing regional market for hollow fiber filtration. The high growth in this regional market can be attributed to the expansion of the biomanufacturing sector, increasing government support, developing R&D infrastructure, and growing outsourcing of bioproduction processes to Asia Pacific countries such as China and India.

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=267011039

Top Key Players:-

The Hollow Fiber Filtration Industry is consolidated due to the presence of a few major players. Asahi Kasei Corporation (Japan), Repligen Corporation (US), GE Healthcare (US), Danaher Corporation (US), and Koch Membrane Systems (US) are the leading players in this market.

Needles Market to Witness Steady Growth in the Near Future

Key factors such growing geriatric population, increasing number of hospitals in emerging markets, and high prevalence of chronic diseases are the major factors driving the growth of the needles market across the globe.

The Needles Market is expected to reach USD 8.47 Billion by 2022, at CAGR of 7.8% during the forecast period.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223979930

Market Segmentation:-              

On the basis of type, the global needles market is segmented into two broad categories, namely, conventional needles and safety needles. The conventional needles market is estimated to command the larger share of the global needles market in 2017. The growing demand for biosimilar products, the increasing incidence of chronic disease, and the expanding injectables market are the key factors contributing to the growth of this market segment.

Based on product, the market is segmented into suture needles, blood collection needles, ophthalmic needles, dental needles, insufflation needles, pen needles, and other needles.

The needles market is segmented into hypodermic, intravenous, intramuscular, and intraperitoneal needles on the basis of delivery mode. The hypodermic needles segment is expected to account for the largest share of the needles market in 2017.

Key Market Drivers: –
1 High Prevalence of Chronic Diseases
2 Growing Geriatric Population
3 Increasing Number of Hospitals in Emerging Markets
4 Increasing Demand for Vaccines

Regional Analysis:-

As of 2016, North America held the largest share of the global needles market, followed by Europe. Its dominant share is attributed to the rising incidence of chronic diseases, initiatives by different organizations for the reduction in blood borne infections, and increasing prevalence of cardiovascular diseases.

Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=223979930

Top Key Players:-

The key players in the global needles market are Hamilton Company (U.S.), Medtronic plc (Ireland), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S.), Terumo Corporation (Japan), Novo Nordisk A/s (Denmark), Smiths Medical (U.K.), and Thermo Fisher Scientific (U.S.).

 

Healthcare Interoperability Solutions Market: Trends and Developments

The major factors driving the growth of this market include the growing need to curb increasing healthcare costs and a growing focus on patient-centric care delivery. Moreover, government initiatives for enhancing patient care & safety and government funding for healthcare interoperability are also boosting market growth.

The Healthcare Interoperability Solutions Market is expected to reach USD 4.2 billion by 2024 from an estimated USD 2.3 billion in 2019, at a CAGR of 12.6%.

Download PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17705847

Market Segmentation:-

Based on type, the healthcare interoperability solutions market is segmented into software and services. The services segment is estimated to account for the largest market share in 2019. The large share of this segment can be attributed to the shifting era towards cloud computing and reduced operational costs for better and faster performance of business processes and applications.

Based on software type, the Interoperability solutions Market is segmented into EHR interoperability solutions, lab system interoperability solutions, imaging system interoperability solutions, HIE interoperability solutions, enterprise interoperability solutions, and other interoperability solutions. The HIE interoperability solutions segment is expected to grow at the highest CAGR during the forecast period.

Recent Developments:-

• In 2018, Epic launched the One Virtual System Worldwide, and added new features to its Care Everywhere solution.
• In 2016 Cerner opened a Health center at the Cerner Center in Bangalore, India, which helped the company enter the Indian market and also expand its geographic reach.
• In 2017, Epic launched its Share Everywhere.
• In 2016, Cerner launched its Open Developer Experience (code).

Regional Analysis:-

North America is expected to account for the largest share of the Interoperability solutions Market in 2019, followed by Europe. The dominance of the North American region can be attributed to the rising demand for quality healthcare delivery, a need to curb increasing healthcare expenditure, and the implementation of favorable initiatives & regulations to improve the overall efficiency of healthcare organizations in the region.

Speak To Analyst: – https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=17705847

Top Key Players:-

The prominent players in the Interoperability solutions Market are Cerner Corporation (US), Infor, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), Koninklijke Philips NV (Netherlands), InterSystems Corporation (US), Orion Health Group Limited (New Zealand), iNTERFACEWARE (Canada), Quality Systems, Inc. (US), OSP Labs (US), Epic Systems Corporation (US), ViSolve, Inc. (US), and Jitterbit (US).

Ophthalmic Equipment Market to Witness Steady Growth in the Near Future

The rapid growth in the geriatric population, rising prevalence of eye diseases, and technological advancements in ophthalmic devices are the major factors driving the growth of this market.

The Ophthalmic Equipment Market  size is projected to reach USD 63.3 billion by 2025 from USD 52.8 billion in 2020, at a CAGR of 3.7% during the forecast period.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155637364

Market Segmentation:-

Based on product, the ophthalmic equipment market is categorized mainly into diagnostic & monitoring devices, surgical devices, and vision care products. In 2019, the vision care products segment was expected to account for the largest share of the ophthalmology devices market. The large share of this segment can primarily be attributed to the high prevalence of eye disorders such as myopia, hyperopia, astigmatism, and presbyopia. In addition to this, technological advancements in lens materials, growing awareness about eyesight correction, and rising trends in eyewear, such as styled sunglasses and advanced contact lenses boasting extra comfort, have further stimulated the adoption of vision care products.

Recent Developments

• In May 2020, Bausch + Lomb Launched its first EDOF IOL LuxSmart and a monofocal IOL LuxGood with preloaded delivery system and pure refractive optics (PRO) technology.
• In April 2020, Haag-Streit Group (Switzerland) acquired VRmagic Holding AG (Germany) to strengthen Haag-Streit’s leading position in the ophthalmology market
• In February 2020, Bausch + Lomb (Canada)collaborated with Prevent Blindness (US) o raise awareness about AMD through social media pages to share information about AMD with the public.
• In September 2019, Johnson & Johnson Vision Care (US) launched ACUVUE VITA contact lenses for astigmatism in the US
• In February 2019, Carl Zeiss Meditec (Germany)collaborated with Christoffel Mission for the Blind (CBM) (Germany)to open a training center in Pune, India in collaboration with the Poona Blind Men Association

End User:-

Based on end-user, the ophthalmology devices marketis segmented into consumers, hospitals, specialty clinics & ambulatory surgery centers (ASCs), and other end users. specialty clinics & ambulatory surgery centers (ASCs) are expected to grow at the highest CAGR during the forecast period.

Regional Analysis:-

North America is expected to account for the largest share of the ophthalmology devices market in 2019, followed by Europe. In addition, factor such as the growing awareness and uptake of ophthalmic treatments and surgeries and the availability of advanced ophthalmic devices in this region are also driving the growth of the ophthalmic equipment market in North America.

Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=155637364

Top Key Players:-

The prominent players in this market are EssilorLuxottica (France), Alcon (US), Johnson & Johnson Vision Care (US), HOYA Corporation (Japan), Bausch + Lomb (US), Carl Zeiss Meditec (Germany), Topcon (Japan), Glaukos Corporation (US), Haag-Streit (Switzerland), NIDEK (Japan), STAAR Surgical (US), Ziemer Ophthalmic Systems (Switzerland), CooperVision, Inc. (US), Oculentis (Germany), Heidelberg Engineering (Germany), Canon (Japan), Optovue (US), Neo Vision (Korea), Lumenis (Israel), Reichert Technologies (US), OPHTEC BV (Netherlands), Heine Optotechnik (Germany), and Luneau Technology (France).

Cell Analysis Market: Emerging Trends and Developments

 

Increasing government funding for cell-based research and the rising incidence of chronic and infectious diseases are the major factors driving the growth of this market.

The report Cell Analysis Market is expected to reach USD 22.7 billion by 2024 from USD 16.0 billion in 2019, at a CAGR of 7.2%. from 2019 to 2024.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157543946

Market Segmentation:-

Based on product, the cell identifications Market is broadly categorized into microscopes, flow cytometry products, spectrophotometers, qPCR products, cell counters, cell microarrays, high-content screening (HCS) systems, and other products. The flow cytometry products segment accounted for the largest market share in 2018. The large share of this segment is primarily attributed to technological advancements, the increasing adoption of flow cytometry techniques in research and academia, growing public-private initiatives in the field of immunology and immuno-oncology research, and the rising incidence and prevalence of chronic diseases.

Based on end user, the cell identifications Market is segmented into hospitals & diagnostic laboratories, research institutes, pharmaceutical & biotechnology companies and CROs, cell culture collection repositories, and other end users. The pharmaceutical & biotechnology companies and CROs segment is expected to register the highest CAGR during the forecast period.

Recent Developments:-

• In 2018, Danaher Corporation launched its Kaluza C Flow Cytometry Analysis Software.
• In 2018, Leica Microsystems opened the first Imaging Center in San Francisco. This center will display the breadth of technologies in microscopes, developed by Leica Microsystems for life sciences research.
• In 2018, Becton, Dickinson and Company (BD) launched its BD FACSymphony S6 cell sorter.

Regional Analysis:-

By region, the cell analysis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest market share, followed by Europe.

Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=157543946

 

Top Key Players:-

The prominent players operating in the cell analysis market are Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), GE Healthcare (US), Agilent Technologies, Inc. (US), Olympus Corporation (Japan), PerkinElmer, Inc. (US), Promega Corporation (US), Tecan Group (Switzerland), Miltenyi Biotec (Germany), Carl Zeiss (Germany), Bio-Rad Laboratories Inc (US), and Sysmex Corporation (Japan).